Galina Marder
Hofstra University
13 Papers
36 Citations
Galina Marder is an academic researcher from Hofstra University. The author has contributed to research in topics: Systemic lupus erythematosus & Tocilizumab. The author has an hindex of 5, co-authored 13 publications.
Chat about Author
Papers
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Dimitrios Giannis,Dimitrios Giannis,Steven L. Allen,James Tsang,Sarah Flint,Sarah Flint,Tamir Pinhasov,Tamir Pinhasov,Stephanie Williams,Stephanie Williams,Gary Tan,Gary Tan,Richa Thakur,Richa Thakur,Christian Leung,Christian Leung,Matthew Snyder,Matthew Snyder,Chirag Bhatia,Chirag Bhatia,David Garrett,David Garrett,Christina Cotte,Christina Cotte,Shelby Isaacs,Shelby Isaacs,Emma Gugerty,Emma Gugerty,Anne Davidson,Anne Davidson,Galina Marder,Austin Schnitzer,Bradley Goldberg,Thomas McGinn,Thomas McGinn,Karina W. Davidson,Karina W. Davidson,Matthew A. Barish,Michael Qiu,Meng Zhang,Mark Goldin,Mark Goldin,Miltiadis Matsagkas,Eleni Arnaoutoglou,Alex C. Spyropoulos,Alex C. Spyropoulos +45 more
TL;DR: In this paper, a prospective registry included consecutive patients with COVID-19 hospitalized within a multihospital system from 1 March to 31 May 2020, and the authors captured demographics, comorbidities, laboratory parameters, medications, postdischarge thromboprophylaxis, and 90-day outcomes.
169
Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
TL;DR: It is suggested that eculizumab may be a potential treatment option for acutely ill patients with secondary TMA due to SLE and/or APS who have failed standard of care.
139
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
Sonali Narain,Dimitre G. Stefanov,Alice S. Chau,Andrew G. Weber,Galina Marder,Blanka Kaplan,Prashant Malhotra,Ona Bloom,Ona Bloom,Audrey Liu,Martin Lesser,Negin Hajizadeh,Negin Hajizadeh,Stuart L. Cohen,Jennifer Cookingham,David Hirschwerk,Naomi I Maria,Sanjaya K. Satapathy,Cristina Sison,Matthew D. Taylor,Michael Qiu +20 more
TL;DR: The combination of corticosteroid use either alone or in combination with tocilizumab or anakinra was associated with reduced hospital mortality for patients with COVID-19 cytokine storm compared to standard of care.
91
IgG4-Related Sclerosing Disease of the Breast in a Male Patient.
TL;DR: A 48-year-old male presented with 4-week history of palpable right upper outer quadrant breast mass associated with skin puckering and reported a family history of breast cancer in his aunt, and an excisional biopsy was performed.
19
Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm': A Retrospective Observational Cohort Study
Sonali Narain,Dimitre G. Stefanov,Alice S. Chau,Andrew G. Weber,Galina Marder,Blanka Kaplan,Prashant Malhotra,Ona Bloom,Audrey Liu,Martin Lesser,Negin Hajizadeh +10 more
TL;DR: Corticosteroid and tocilizumab used in combination, or corticosteroids alone, was associated with reduced hospital mortality for patients with COVID-19 cytokine storm and improved hospital survival compared to standard of care.
13